Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and endogenous substrates to evaluate renal OCT-mediated drug-drug interactions
jRCTs031210406Recruiting
- Sponsor
- consortium
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin, cimetidine and dolutegravir (2 arms), sponsored by consortium. Primary endpoints: Kinetic parameters of endogenous substrates, Pharmacokinetics of metformin, cimetidine, and dolutegravir and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
metformincimetidinedolutegravir
Beyond the preview
Go deeper on jRCTs031210406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210406.